Todos Medical Ltd. Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2021-01-30: Study NCT05226767; Company role Lead sponsor; Phase Phase 2; Status Completed.
- 2018-01-22: Study NCT03343691; Company role Lead sponsor; Phase Observational; Status Unknown.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2021-01-30 | NCT05226767 Effect of Daily Oral Administration of Food Supplement NLC-V in Patients Diagnosed With COVID-19 | Lead sponsor | Phase 2 | Completed | COVID-19 | 31 | 2022-01-20 |
| 2018-01-22 | NCT03343691 Blood Test for Early Detection of Breast Cancer Using Todos Medical -Breast 1(TM-B1) Assay | Lead sponsor | Observational | Unknown | Breast Cancer | 200 | 2019-07-01 |